Загрузка...
Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint
Because of its direct clinical relevance, overall survival is the gold standard endpoint for measuring clinical efficacy. However, achieving improvements in overall survival can be confounded by factors such as crossover to active treatment arms and subsequent treatment with non-experimental active...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3821870/ https://ncbi.nlm.nih.gov/pubmed/21315516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2011.01.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|